Search

Your search keyword '"Arvind Mathur"' showing total 268 results

Search Constraints

Start Over You searched for: Author "Arvind Mathur" Remove constraint Author: "Arvind Mathur"
268 results on '"Arvind Mathur"'

Search Results

1. High throughput and cost-effective purification of small molecules using superficially porous stationary phase columns: An environment friendly approach

7. The response to COVID-19 in Timor-Leste: lessons learnt

11. Knowledge, attitudes, and practices among older adults of Urban Rajasthan toward COVID-19: A cross-sectional survey

12. Burden and management of obstetric fistula in South-East Asian region countries: A systematic review and meta-analysis

20. Study of VVER-1000 OECD LEU and MOX Computational Benchmark with VISWAM Code System

24. HIV and Ageing

25. Cytomegalovirus oesophagitis in an HIV-infected patient

26. HIV-related pulmonary arterial hypertension: A significant cause of mortality and morbidity in HIV/AIDS

29. Retrospective Analysis of Diabetic Admissions: Moving Forward by Looking Back

30. Epidemiology Of Brucellosis in High-Risk Group & PUO Patients of Western – Rajasthan

31. Incidence & Prevalence of Silico tuberculosis in Western Rajasthan: A Retrospective Study of Three Years

32. Validation of a measure of subjective well-being: an abbreviated version of the day reconstruction method.

35. A strategy for evaluation of isotopic enrichment and structural integrity of deuterium labelled compounds by using HR-MS and NMR

38. Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4

40. Synthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272

41. Discovery of (S)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain

42. Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)

43. Development of a Rapid Scale-Up Synthesis of (S)-N-(8-((2-Amino-2,4-dimethylpentyl)oxy)-5H-chromeno[3,4-c]pyridin-2-yl)acetamide, a Potent Adaptor-Associated Kinase 1 Inhibitor

44. Regioselective synthesis of N1-substituted-4-nitropyrazole-5-carboxylates via the cyclocondensation of ethyl 4-(dimethylamino)-3-nitro-2-oxobut-3-enoate with substituted hydrazines

45. Use of Carbonyldiimidazole as an Activator of Formic Acid in a Tris(dibenzylideneacetone)dipalladium-Catalyzed Formylation of Aryl Iodides

47. Visible-Light-Promoted Radical Cyclization of N-Arylvinylsulfonamides: Synthesis of CF3/CHF2/CH2CF3-Containing 1,3-Dihydrobenzo[c]isothiazole 2,2-Dioxide Derivatives

48. BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate

49. Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders

50. Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

Catalog

Books, media, physical & digital resources